Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 65.18
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Colinz Laboratories Ltd. engages in the manufacture of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectable, ointments, and creams. The firm has certain products for gynecology, cardiology, and gastroenterology. Its products category includes allopathy, ayurvedics, and nutraceuticals. The company was founded on October 6, 1986 and is headquartered in Mumbai,...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB
Data is available to registered users only
Buy
Sell